SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001340881-23-000001
Filing Date
2023-01-09
Accepted
2023-01-06 21:31:43
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 9506
2 DRAPKIN POWER OF ATTORNEY DrapkinPOA2023.txt EX-24 4482
  Complete submission text file 0001340881-23-000001.txt   15350
Mailing Address PREDIX PHARMACEUTICALS HOLDINGS, INC. 4 MAGUIRE ROAD LEXINGTON MA 02421
Business Address
Drapkin Kimberlee C (Reporting) CIK: 0001340881 (see all company filings)

Type: 144

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Subject) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37998 | Film No.: 23516360
SIC: 2836 Biological Products, (No Diagnostic Substances)